Sanofi's US-based CEO Viehbacher resigns after board votes to remove him
So it appears the future of Sanofi’s CEO Christopher Viehbacher was on the agenda after all.
Archives for October 29, 2014
BioSilta hopes to grow growth systems business with new UK headquarters
The UK beats Finland for business opportunities according to the CEO of microbial growth system developer BioSilta, who said moving the firm to St. Ives, Cambridgeshire has improved its access to larger markets.
Amgen chases $3bn biosimilar market with three new programs, biomanufacturing capabilities
Despite plans to lay off more than 2,000 employees, Amgen is preparing for a biosimilar onslaught and expanding its portfolio to nine biosimilar programs.